Health spending continues to rise faster than economic growth in most OECD countries, maintaining a trend observed since the 1970s. Health spending reached 9.5% of GDP on average in 2009, the most recent year for which figures are available, up from 8.8% in 2008, according to OECD Health Data 2011.

Growth in health spending slowed or fell in real terms in 2010 in almost all OECD countries, reversing a long-term trend of rapid increases, according to OECD Health Data 2012.

This workshop will convene leading experts from health and finance backgrounds in government, academia, and international organisations to take stock of progress in health expenditure forecasting and to discuss future directions, in light of policy needs and recent advancements in techniques, detailed data and computing power.

Health spending fell across the European Union in 2010, as cash-strapped governments curbed outlays to help cut budgetary deficits, according to Health at a Glance: Europe 2012, a new joint report by the OECD and the European Commission.

OECD Health Working Papers No. 60: Health Spending Growth at Zero: Which Countries, Which Sectors Are Most Affected?

This paper provides new projections of public spending on health and long-term care for OECD countries and the BRIICS countries (Brazil, Russia, India, Indonesia, China and South Africa). Despite the inevitable uncertainty surrounding projections, they suggest a rapidly rising trend over the next 50 years.

After falling sharply in 2010, health spending remained flat across OECD countries in 2011 as the economic crisis continued to have an impact, particularly in those European countries hardest hit by the crisis, according to OECD Health Data 2013.

Ireland continues to make substantive headway in improving health outcomes, but more can be done in reducing risk-factors for major diseases and improving value-for-money in health spending, according to a new OECD report.

Total health spending has fallen in one of three OECD countries between 2009 and 2011, with those hardest hit by the crisis most affected. This is a sharp reversal from the strong growth in the years prior to the crisis, according to a new OECD report.

Health spending per capita in real terms fell by 2% in Italy in 2011, and is estimated to have fallen by a further 0.4% in 2012. Spending per capita also fell in 10 other European countries between 2009 and 2011, following the recession and the need for fiscal consolidation, according to a new OECD report.

Health spending has fallen in the United Kingdom in 2010 and 2011 for the first time since the 1970s, according to a new OECD report. Health at a Glance 2013 says that spending in real terms per capita fell by 1.1% in 2011, following a 2.5% decline in 2010.

Health spending has started to rise again after stagnating or even falling in many OECD countries during the crisis. But the pace of growth remains well below pre-crisis rates, especially in Europe, according to OECD Health Statistics 2014.

The USA has exceptional levels of health-care expenditure, but growth slowed dramatically in recent years, amidst major efforts to close the coverage gap with other OECD countries.

Several OECD countries have published their plans for the development of a future bioeconomy, in which bio-based materials and production techniques will contribute significantly to economic and environmental sustainability. The case for support for bio-based chemicals and plastics therefore warrants serious attention.

Many European countries saw further reductions in health spending in 2013, according to OECD Health Statistics 2015. Health spending continued to shrink in Greece, Italy and Portugal in 2013. Most countries in the European Union reported real per capita health spending below the levels of 2009. Outside of Europe, health spending has been growing at around 2.5% per year since 2010.

This paper looks at recent trends in pharmaceutical spending across OECD countries. It examines the drivers of recent spending trends, highlighting differences across therapeutic classes, and then looks at emerging challenges for policy makers in the management of pharmaceutical spending.

Asia-Pacific countries should strengthen their health systems and sharply increase spending to deliver effective universal coverage in order to meet the changing needs of their fast ageing populations, according to a new OECD report.

Statistics on biotechnology firms, biotechnology R&D (including public sector expenditures), biotech applications and patents.

This one-pager note presents key findings for Australia from Society at a Glance 2011 - OECD Social indicators. This 2011 publication also provides a special chapter on unpaid work across the OECD.

This note presents key findings for Australia from Society at a Glance 2014 - OECD Social indicators. This 2014 publication also provides a special chapter on: the crisis and its aftermath: a “stress test” for societies and for social policies.

Going for Growth 2015: Country note for Australia

In a boost for international efforts to strengthen co-operation against offshore tax evasion, seven new countries have joined the agreement to exchange information automatically under the OECD/G20 standard.

Australia performs well in terms of overall population health status. At 82.2 years, life expectancy is the sixth highest in the OECD, and the country’s record on breast and colorectal cancer survival is among the best. Australia has one of the lowest rates of tobacco consumption (12.8% of the population aged 15 and over), but it is the fifth most obese country in the OECD (28.3% of the population aged 15 and over).

This country note provides an environmental tax and carbon pricing profile for Australia. It shows environmentally related tax revenues, taxes on energy use and effective carbon rates.

This country note presents student performance in science, reading and mathematics, and measures equity in education in Australia. The interactive charts allow you to compare results with other countries participating in the OECD Programme for International Student Assessment (PISA).

Selected findings for Australia from the report "The Pursuit of Gender Equality: An Uphill Battle"

Selected findings for Australia from the report "Preventing Ageing Unequally"

Key findings for Australia from the report "Pensions at a Glance 2017"

This note presents marginal effective tax rates (METRs) that summarise the tax system’s impact on the incentives to make an additional investment in a particular type of savings. By comparing METRs on different types of household savings, we can gain insights into which assets or savings types receive the most favourable treatment from the tax system.

A Broken Social Elevator? Key findings for Australia

This country note for Australia provides detail on the proportion of CO2 emissions from energy use subject to different effective carbon rates (ECR), as well as on the level and components of average ECRs in each of the six economic sectors (road transport, off-road transport, industry, agriculture and fishing, residential & commercial, and electricity).

The Australian standard GST rate is 10.0%, which is below the OECD average. The average VAT/GST¹ standard rate in the OECD was 19.3% as of 1 January 2019. Australia has an extensive list of goods and services that are GST-free. GST was introduced in Australia in 2000 at a standard rate of 10.0% and has remained at this rate throughout.

About 36% of Australian jobs face a significant or high risk of automation. While this is less than the OECD average (46%), it means that a sizeable share of adults will need to upskill or retrain to meet the needs of future jobs.

Australia's tax-to-GDP ratio was 27.8% in 2016* (latest available data), below the OECD average (34.2%) by 6.4 percentage points, and above the LAC and Africa (21)* averages (22.8% and 18.2%, respectively).

Australia has one of the highest rates of obesity: nearly one in three adults are obese. As a result, Australians live on average 2.7 years less due to overweight. The impact on the economy is large: overweight accounts for 8.6% of health expenditure; and lowers labour market outputs by the equivalent of 371 thousand full time workers per year. Combined, this means that overweight reduces Australia’s GDP by 3.1%.

This country note explains how Australia taxes energy use. The note shows the distribution of effective energy tax rates across all domestic energy use. It also details the country-specific assumptions made when calculating effective energy tax rates and matching tax rates to the corresponding energy base.

Australia spends 9.3% of its GDP on health, slightly higher than the OECD average, and is projected to reach 13% by 2030. Australia also has more nurses (11.7 per 1000 people, compared to an OECD average of 8.8) and slightly more doctors (3.7 doctors versus an OECD average of 3.5) serving the population than in many OECD countries. These resources have contributed to good health outcomes.

Key findings for Australia from the report "Pensions at a Glance 2019"

The tax-to-GDP ratio in Australia increased by 0.9 percentage points from 27.6% in 2016 to 28.5% in 2017 (latest year available). The corresponding figures for the OECD average were a decrease of 0.2 percentage points from 34.4% to 34.2% over the same period.

The tax wedge for the average single worker in Australia decreased by 1.0 percentage point from 28.9 in 2018 to 27.9 in 2019. The OECD average tax wedge in 2019 was 36.0 (2018, 36.1). In 2019 Australia had the 30th lowest tax wedge among the 36 OECD member countries, occupying the same position in 2018.

Unemployment Rate in India increased to 7.80 percent in February from 7.20 percent in January of 2020. Unemployment Rate in India averaged 7.34 percent from 2018 until 2020, reaching an all time high of 8.20 percent in August of 2019 and a record low of 6.70 percent in November of 2018. In India, the unemployment rate is estimated by directly interviewing a large sample of randomly selected households. Centre for Monitoring Indian Economy Consumer Pyramids panel of households includes over 174,405 households including over 522,000 members who are over 15 years old. This page provides - India Unemployment Rate - actual values, historical data, forecast, chart, statistics, economic calendar and news.

This note presents key findings for Japan from Society at a Glance 2014 - OECD Social indicators. This 2014 publication also provides a special chapter on: the crisis and its aftermath: a “stress test” for societies and for social policies.

Going for Growth 2015: Key findings for Japan

日本の医療の質は総じて非常に良好だが、糖尿病の管理、心臓発作（急性心筋梗塞）の治療とがん対策はさらに改善・強化できるだろう。

The quality of health care is generally very good in Japan but further improvement can be made in the management of diabetes, treatment of heart attack (AMI), and cancer control. In Japan, per capita spending on pharmaceuticals is the second highest in the OECD after the United States. Spending on pharmaceuticals could be reduced by increasing the share of the generic market.

This country note provides an environmental tax and carbon pricing profile for Japan. It shows environmentally related tax revenues, taxes on energy use and effective carbon rates.

Selected findings for Japan from the report "The Pursuit of Gender Equality: An Uphill Battle"

Selected findings for Japan from the report "Preventing Ageing Unequally"

Key findings for Japan from the report "Pensions at a Glance 2017"

This note presents marginal effective tax rates (METRs) that summarise the tax system’s impact on the incentives to make an additional investment in a particular type of savings. By comparing METRs on different types of household savings, we can gain insights into which assets or savings types receive the most favourable treatment from the tax system.